IMNM logo

Immunome, Inc. (IMNM) Operating Profit

Annual Operating Profit:

-$153.46M-$124.73M(-434.17%)
December 31, 2024

Summary

  • As of today, IMNM annual operating income is -$153.46 million, with the most recent change of -$124.73 million (-434.17%) on December 31, 2024.
  • During the last 3 years, IMNM annual operating profit has fallen by -$128.25 million (-508.86%).
  • IMNM annual operating profit is now -1881.87% below its all-time high of -$7.74 million, reached on December 31, 2018.

Performance

IMNM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMincome statement metrics

Quarterly Operating Profit:

-$60.14M-$13.66M(-29.39%)
September 30, 2025

Summary

  • As of today, IMNM quarterly operating income is -$60.14 million, with the most recent change of -$13.66 million (-29.39%) on September 30, 2025.
  • Over the past year, IMNM quarterly operating profit has dropped by -$16.32 million (-37.25%).
  • IMNM quarterly operating profit is now -2165.08% below its all-time high of -$2.65 million, reached on March 31, 2020.

Performance

IMNM Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMincome statement metrics

TTM Operating Profit:

-$206.85M-$16.32M(-8.57%)
September 30, 2025

Summary

  • As of today, IMNM TTM operating income is -$206.85 million, with the most recent change of -$16.32 million (-8.57%) on September 30, 2025.
  • Over the past year, IMNM TTM operating profit has increased by +$103.93 million (+33.44%).
  • IMNM TTM operating profit is now -7504.78% below its all-time high of -$2.72 million, reached on September 30, 2019.

Performance

IMNM TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

IMNM Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-434.2%-37.3%+33.4%
3Y3 Years-508.9%-604.7%-459.7%
5Y5 Years-1383.0%-2034.1%-2426.3%

IMNM Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-508.9%at low-1245.1%+54.5%-812.7%+33.4%
5Y5-Year-1383.0%at low-2034.1%+54.5%-2426.3%+33.4%
All-TimeAll-Time-1881.9%at low-2165.1%+54.5%-7504.8%+33.4%

IMNM Operating Profit History

DateAnnualQuarterlyTTM
Sep 2025
-
-$60.14M(-29.4%)
-$206.85M(-8.6%)
Jun 2025
-
-$46.48M(-4.1%)
-$190.53M(-3.5%)
Mar 2025
-
-$44.64M(+19.7%)
-$184.06M(+32.3%)
Dec 2024
-$153.46M(-434.2%)
-$55.60M(-26.9%)
-$271.72M(+12.6%)
Sep 2024
-
-$43.82M(-9.5%)
-$310.78M(-14.4%)
Jun 2024
-
-$40.01M(+69.8%)
-$271.59M(-14.4%)
Mar 2024
-
-$132.30M(-39.8%)
-$237.36M(-116.7%)
Dec 2023
-$28.73M(+22.1%)
-$94.65M(-1943.0%)
-$109.53M(-383.3%)
Sep 2023
-
-$4.63M(+19.7%)
-$22.66M(+14.7%)
Jun 2023
-
-$5.77M(-29.1%)
-$26.57M(+10.6%)
Mar 2023
-
-$4.47M(+42.6%)
-$29.72M(+19.5%)
Dec 2022
-$36.90M
-$7.79M(+8.8%)
-$36.90M(+0.2%)
Sep 2022
-
-$8.53M(+4.4%)
-$36.96M(-2.2%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$8.93M(+23.4%)
-$36.15M(-9.7%)
Mar 2022
-
-$11.65M(-48.6%)
-$32.96M(-30.8%)
Dec 2021
-$25.20M(-105.6%)
-$7.84M(-1.6%)
-$25.20M(-17.6%)
Sep 2021
-
-$7.72M(-34.5%)
-$21.43M(-29.7%)
Jun 2021
-
-$5.74M(-47.3%)
-$16.53M(-22.4%)
Mar 2021
-
-$3.90M(+4.3%)
-$13.50M(-10.1%)
Dec 2020
-$12.26M(-18.5%)
-$4.07M(-44.5%)
-$12.26M(-49.7%)
Sep 2020
-
-$2.82M(-3.8%)
-$8.19M(-1.2%)
Jun 2020
-
-$2.71M(-2.3%)
-$8.09M(-50.5%)
Mar 2020
-
-$2.65M(+2.4%)
-$5.38M(-97.6%)
Dec 2019
-$10.35M(-33.6%)
-
-
Sep 2019
-
-$2.72M
-$2.72M
Dec 2018
-$7.74M
-
-

FAQ

  • What is Immunome, Inc. annual operating income?
  • What is the all-time high annual operating profit for Immunome, Inc.?
  • What is Immunome, Inc. annual operating profit year-on-year change?
  • What is Immunome, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Immunome, Inc.?
  • What is Immunome, Inc. quarterly operating profit year-on-year change?
  • What is Immunome, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Immunome, Inc.?
  • What is Immunome, Inc. TTM operating profit year-on-year change?

What is Immunome, Inc. annual operating income?

The current annual operating profit of IMNM is -$153.46M

What is the all-time high annual operating profit for Immunome, Inc.?

Immunome, Inc. all-time high annual operating income is -$7.74M

What is Immunome, Inc. annual operating profit year-on-year change?

Over the past year, IMNM annual operating income has changed by -$124.73M (-434.17%)

What is Immunome, Inc. quarterly operating income?

The current quarterly operating profit of IMNM is -$60.14M

What is the all-time high quarterly operating profit for Immunome, Inc.?

Immunome, Inc. all-time high quarterly operating income is -$2.65M

What is Immunome, Inc. quarterly operating profit year-on-year change?

Over the past year, IMNM quarterly operating income has changed by -$16.32M (-37.25%)

What is Immunome, Inc. TTM operating income?

The current TTM operating profit of IMNM is -$206.85M

What is the all-time high TTM operating profit for Immunome, Inc.?

Immunome, Inc. all-time high TTM operating income is -$2.72M

What is Immunome, Inc. TTM operating profit year-on-year change?

Over the past year, IMNM TTM operating income has changed by +$103.93M (+33.44%)
On this page